<DOC>
	<DOCNO>NCT01801982</DOCNO>
	<brief_summary>This single center study monitor developmental progress PPHN patient receive iv sildenafil study A1481276 . Two visit conduct , 12 24 month follow end study drug infusion .</brief_summary>
	<brief_title>A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil Persistent Pulmonary Hypertension Newborn ( PPHN )</brief_title>
	<detailed_description>This study monitor developmental progress PPHN patient 2 year follow study treatment , use Bayley III Hammersmith tool . Data explore descriptive statistic .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Any subject receive sildenafil treatment study A1481276 . Signed date informed consent document legal guardian . Any subject receive sildenafil treatment study A1481276 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>PPHN ; development progress PPHN ; developmental progress sildenafil .</keyword>
</DOC>